<code id='A051406666'></code><style id='A051406666'></style>
    • <acronym id='A051406666'></acronym>
      <center id='A051406666'><center id='A051406666'><tfoot id='A051406666'></tfoot></center><abbr id='A051406666'><dir id='A051406666'><tfoot id='A051406666'></tfoot><noframes id='A051406666'>

    • <optgroup id='A051406666'><strike id='A051406666'><sup id='A051406666'></sup></strike><code id='A051406666'></code></optgroup>
        1. <b id='A051406666'><label id='A051406666'><select id='A051406666'><dt id='A051406666'><span id='A051406666'></span></dt></select></label></b><u id='A051406666'></u>
          <i id='A051406666'><strike id='A051406666'><tt id='A051406666'><pre id='A051406666'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:5
          Courtesy Sanofi

          LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion.

          The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue. Inhibrx has completed Phase 1 testing of the drug and is enrolling patients in a Phase 2 trial.   

          advertisement

          Inhibrx’s other drug candidates, including its line of cancer-targeting immunotherapies, will be portioned out into a new company that will continue to be called Inhibrx. Mark Lappe, the founder and CEO of Inhibrx, will lead the spun-out company. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Medicare to pay more for cardiac rehab in hospital outpatient clinics
          Medicare to pay more for cardiac rehab in hospital outpatient clinics

          Medicareplanstopaymoreforatypeofcardiacrehabilitationthattakesplaceincertainoutpatientclinicsownedby

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          Data integrity in scientific journals requires "effort" by publishers, institutions

          ScientificwatchdogsSholtoDavid(right)andElisabethBikjoinSTAT'sJonathenWosenattheSTATBreakthroughSumm